SCSC Reports Results

ScanSource (SCSC) reported robust Q4 2025 results, with net sales up nearly 9% and non-GAAP EPS rising 27.5% to $1.02, underpinned by a 120 basis point increase in full-year gross profit margin driven by recurring revenues growing to 32.8% of consolidated gross profit. The company introduced new three-year strategic goals aiming for 50% recurring gross profit, strategic acquisitions, and disciplined capital allocation, alongside FY26 guidance projecting net sales of $3.1B-$3.13B and adjusted EBITDA of $150M-$160M. This strategic pivot towards higher-margin recurring revenue, supported by strong free cash flow generation and share repurchases, positions ScanSource for resilient long-term growth and enhanced shareholder returns, despite anticipating low single-digit growth in H1 FY26 due to macroeconomic uncertainty.

Analysis

ScanSource reported a strong fourth quarter for fiscal 2025, with net sales increasing by nearly 9% and non-GAAP EPS rising 27.5% year-over-year to $1.02. The fundamental driver of this performance is a strategic pivot toward higher-margin recurring revenues, which grew from 27.5% to 32.8% of consolidated gross profit, directly contributing to a 120 basis point expansion in full-year gross profit margin to 13.4%. Management has formalized this strategy with a new three-year goal to push recurring gross profit toward 50%. While the Intellisys segment showed modest 1% growth, it is undergoing strategic investment in AI and customer experience platforms to counter private equity-backed competitors, with end-user billings growing 4.5%. The company's financial position is robust, evidenced by $104 million in full-year free cash flow, a near-zero net debt position, and a 13.6% return on invested capital. This strength facilitates a disciplined capital allocation policy that balances strategic acquisitions with significant shareholder returns, including $107 million in share repurchases during the year. Fiscal 2026 guidance projects net sales of $3.1 billion to $3.13 billion and adjusted EBITDA of $150 million to $160 million, though it prudently anticipates low single-digit growth in the first half due to macroeconomic uncertainty, with an expected acceleration in the second half.

Key Decisions for Investors

• Investors should evaluate ScanSource based on its successful strategic shift toward a higher-margin, recurring revenue model, which is fundamentally improving earnings quality and margin profile.
• It is critical to monitor the company's execution against its fiscal 2026 guidance, particularly the forecasted revenue acceleration in the second half, as well as progress toward the new three-year target of reaching 50% recurring gross profit.
• Consider the company's strong balance sheet and robust free cash flow, which provide flexibility for both value-accretive M&A to expand its recurring revenue base and continued capital returns to shareholders through buybacks.